Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Not applicable Interventional

RF Ablation of the Trigone for the Treatment of UUI

ClinicalTrials.gov ID: NCT04408352

Public ClinicalTrials.gov record NCT04408352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Selective Bladder Denervation Using RF Energy for the Treatment of UUI

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this pivotal study is to collect data on the safety and effectiveness of the Hologic trigone RF ablation device to reduce urgency urinary incontinence. Up to 325 subjects will be enrolled with 225 randomized (2:1) and treated at up to 35 sites in the U.S. Additional sites in Canada, Australia, Europe, and other countries may also be considered. Sites outside of the U.S. cannot randomize more than 25% of subjects.

Study identification

NCT ID
NCT04408352
Recruitment status
Suspended
Study type
Interventional
Phase
Not applicable
Lead sponsor
Hologic, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2020 (Actual)
Primary completion
Feb 2030 (Estimated)
Completion
May 2030 (Estimated)
Last update posted
Feb 28, 2024

2020 – 2030

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Cypress Medical Research Center, LLC Wichita Kansas 67226 —
Regional Urology, LLC Shreveport Louisiana 71106 —
UPMC Magee Womens Hospital Pittsburgh Pennsylvania 15213 —
Alleghany Health Network Pittsburgh Pennsylvania 15224 —
Center for Pelvic Health Franklin Tennessee 37067 —
Virginia Urology Richmond Virginia 23230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04408352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04408352 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →